These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29577795)

  • 1. Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series.
    Forfori F; Brogi E; Sidoti A; Giraudini M; Monti G; Zarrillo N; Cantaluppi V; Ronco C
    Int J Artif Organs; 2018 Jun; 41(6):319-324. PubMed ID: 29577795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxin B Direct Hemoperfusion Using Regional Citrate-Calcium Anticoagulation: A Case Report.
    Sidoti A; Brogi E; Morse J; Collareta M; Vetrugno L; Giunta F; Forfori F
    A A Case Rep; 2016 Dec; 7(11):232-235. PubMed ID: 27669028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin dosing score protocol for anticoagulation during polymyxin B hemoperfusion.
    Lee CT; Chao A; Lai CH; Yeh YC
    J Formos Med Assoc; 2018 Jul; 117(7):652-653. PubMed ID: 29555453
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
    Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
    Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Koga Y; Oba U; Takimoto T; Suminoe A; Takada H; Hara T
    Shock; 2013 Sep; 40(3):233. PubMed ID: 23949391
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Effects and Outcomes After Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates.
    Nishizaki N; Hara T; Obinata K; Nakagawa M; Shimizu T
    Pediatr Crit Care Med; 2020 Feb; 21(2):156-163. PubMed ID: 31568052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Description of the hemodynamic and respiratory effects of hemoperfusion treatment with polymyxin B in patients with abdominal septic shock].
    Navarro R; Guerrero M; González M; Quecedo L; García A; Ramasco F
    Rev Esp Anestesiol Reanim; 2013; 60(6):344-7. PubMed ID: 23276381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septic shock from descending necrotizing mediastinitis - combined treatment with IgM-enriched immunoglobulin preparation and direct polymyxin B hemoperfusion: a case report.
    Pota V; Passavanti MB; Sansone P; Pace MC; Peluso F; Fiorelli A; Aurilio C
    J Med Case Rep; 2018 Mar; 12(1):55. PubMed ID: 29499757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
    Ishizuka M; Terasaki A; Kubota K
    J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan.
    Fujimori K; Tarasawa K; Fushimi K
    Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients.
    Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y;
    Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Vincent JL
    JAMA; 2009 Nov; 302(18):1968; author reply 1969-70. PubMed ID: 19903915
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Amaral AC
    JAMA; 2009 Nov; 302(18):1968-9; author reply 1969-70. PubMed ID: 19903914
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion.
    Ishizuka M; Tago K; Kubota K
    Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B hemoperfusion in septic shock: just look at the evidence!
    Antonelli M; Cutuli SL; Ronco C
    Intensive Care Med; 2015 Sep; 41(9):1731-2. PubMed ID: 26197847
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience of direct hemoperfusion using polymyxin B-immobilized fiber on patients with endotoxin shock from urosepsis].
    Ushida H; Koizumi S; Johnin K; Katoh K; Okada Y
    Hinyokika Kiyo; 2001 May; 47(5):329-31. PubMed ID: 11433754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymyxin B hemoperfusion and mortality in abdominal septic shock.
    Kida Y
    JAMA; 2009 Nov; 302(18):1969; author reply 1969-70. PubMed ID: 19903916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.